Zia Uddin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zia Uddin has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Al Amin
Department of Pharmacy, Faculty of Health and Life Sciences Daffodil International University Dhaka Bangladesh
1 shared publicationAziz Unnisa
Department of Pharmaceutical Chemistry, College of Pharmacy University of Ha'il Ha'il Saudi Arabia
1 shared publication- Farjana Nawrin
Department of Pharmacy, University of science and Technology Chittagong (USTC), Bangladesh
1 shared publication Irfan Ahmad
Department of Clinical Laboratory Sciences, College of Applied Medical Science King Khalid University Abha Saudi Arabia
1 shared publicationJafrin Akter Eisha
Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of Science and Technology Chittagong, Foy’s Lake, Chattogram, Bangladesh
1 shared publicationKusuma Praveen Kumar
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences Delhi Pharmaceutical Sciences and Research University (DPSRU), Govt. of N.C.T. of Delhi New Delhi India
1 shared publication
Latest Publications
- 27 October 2026
- Published by Springer Nature in In Silico Pharmacology
- Vol. 14 (3) , 274
Nutritional profiling and pharmacological investigation of Baccaurea motleyana peel and seed through experimental and computational approach
- 27 October 2026
- Published by Springer Nature in In Silico Pharmacology
- Vol. 14 (3) , 274
Nutritional profiling and pharmacological investigation of Baccaurea motleyana peel and seed through experimental and computational approach
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Antipyretic, Analgesic, and Anti‐Inflammatory Activities of Artocarpus chaplasha Seeds Validated by In Silico Analysis
Background: The rare native Bangladeshi medicinal plant Artocarpus chaplasha has long been utilized to treat different illnesses. While its bark, leaves, and roots have folk uses, the seeds remain underexplored. The research aimed to evaluate the antipyretic, analgesic, and anti‐inflammatory properties of the methanolic seed extract to substantiate traditional medicine claims and identify therapeutic potential. Methods: Mature seeds were collected, shade‐dried, powdered, and soaked in methanol. Female Swiss albino mice were utilized for in vivo assays. Antipyretic activity was assessed via pyrexia induced by brewer’s yeast, analgesic potential through acetic acid–induced writhing and paw licking tests induced by formalin, and anti‐inflammatory activity via formalin and carrageenan‐induced paw edema models. Standard drugs (paracetamol, diclofenac, morphine, and indomethacin) served as controls. Molecular docking was performed against analgesic (PDB ID: 5DU1), anti‐inflammatory (PDB ID: 5O0X), and antipyretic activity (PDB ID: 5F15) for 2 selected phytoconstituents, tetra decanoic acid, 10,13‐dimethyl‐, methyl ester, and neophytadiene. Results: The extract significantly ( p < 0.005–0.001) reduced yeast‐induced hyperthermia in a dose‐dependent manner, comparable to paracetamol. Analgesic assessment showed marked writhing inhibition (56.52%) and notable decrease in paw licking duration in both neurogenic and inflammatory phases, suggesting central and peripheral antinociceptive actions. Anti‐inflammatory evaluation revealed substantial inhibition of paw edema in both models, with stronger effects at higher doses. Conclusion: A. chaplasha methanolic seed extract possesses potent antipyretic, analgesic, and anti‐inflammatory activities, validating its traditional use and indicating the presence of promising bioactive compounds. Further phytochemical profiling and mechanistic studies are needed for potential plant‐derived therapeutics.
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Open AccessAntipyretic, Analgesic, and Anti‐Inflammatory Activities of Artocarpus chaplasha Seeds Validated by In Silico Analysis
Background: The rare native Bangladeshi medicinal plant Artocarpus chaplasha has long been utilized to treat different illnesses. While its bark, leaves, and roots have folk uses, the seeds remain underexplored. The research aimed to evaluate the antipyretic, analgesic, and anti‐inflammatory properties of the methanolic seed extract to substantiate traditional medicine claims and identify therapeutic potential. Methods: Mature seeds were collected, shade‐dried, powdered, and soaked in methanol. Female Swiss albino mice were utilized for in vivo assays. Antipyretic activity was assessed via pyrexia induced by brewer’s yeast, analgesic potential through acetic acid–induced writhing and paw licking tests induced by formalin, and anti‐inflammatory activity via formalin and carrageenan‐induced paw edema models. Standard drugs (paracetamol, diclofenac, morphine, and indomethacin) served as controls. Molecular docking was performed against analgesic (PDB ID: 5DU1), anti‐inflammatory (PDB ID: 5O0X), and antipyretic activity (PDB ID: 5F15) for 2 selected phytoconstituents, tetra decanoic acid, 10,13‐dimethyl‐, methyl ester, and neophytadiene. Results: The extract significantly ( p < 0.005–0.001) reduced yeast‐induced hyperthermia in a dose‐dependent manner, comparable to paracetamol. Analgesic assessment showed marked writhing inhibition (56.52%) and notable decrease in paw licking duration in both neurogenic and inflammatory phases, suggesting central and peripheral antinociceptive actions. Anti‐inflammatory evaluation revealed substantial inhibition of paw edema in both models, with stronger effects at higher doses. Conclusion: A. chaplasha methanolic seed extract possesses potent antipyretic, analgesic, and anti‐inflammatory activities, validating its traditional use and indicating the presence of promising bioactive compounds. Further phytochemical profiling and mechanistic studies are needed for potential plant‐derived therapeutics.
- Open Access
- 7 February 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (3) , 441-457
Bird's eye view of natural products for the development of new anti‐HIV agents: Understanding from a therapeutic viewpoint
Acquired immune deficiency syndrome (AIDS) is the name used to describe several potentially life‐threatening infections and disorders that happen when HIV has severely compromised the immune system. The primary effect of HIV is to decrease host immunity, exposing the host to external pathogens. The development of pharmaceutical drugs that directly cure the infection is crucial because of the current wide‐ranging epidemic of HIV. Most therapeutic anti‐HIV drugs are nucleosides. However, their high toxicity and potential for drug resistance restrict their use. Many of the most effective clinical drugs used to inhibit HIV, the activation of latent HIV, and AIDS have been obtained from natural sources. This review focuses on potential natural medicinal products for treating and managing HIV and AIDS. Notwithstanding, further clinical research studies are needed to understand the subject and its dynamics.
- 7 February 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (3) , 441-457
Open AccessBird's eye view of natural products for the development of new anti‐HIV agents: Understanding from a therapeutic viewpoint
Acquired immune deficiency syndrome (AIDS) is the name used to describe several potentially life‐threatening infections and disorders that happen when HIV has severely compromised the immune system. The primary effect of HIV is to decrease host immunity, exposing the host to external pathogens. The development of pharmaceutical drugs that directly cure the infection is crucial because of the current wide‐ranging epidemic of HIV. Most therapeutic anti‐HIV drugs are nucleosides. However, their high toxicity and potential for drug resistance restrict their use. Many of the most effective clinical drugs used to inhibit HIV, the activation of latent HIV, and AIDS have been obtained from natural sources. This review focuses on potential natural medicinal products for treating and managing HIV and AIDS. Notwithstanding, further clinical research studies are needed to understand the subject and its dynamics.